{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:17:03Z","timestamp":1784895423954,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cranial radiotherapy (cRT) can induce hormonal deficiencies as a consequence of significant doses to the hypothalamic-pituitary (HP) axis. In contrast to profound endocrinological follow-up data from survivors of childhood cancer treated with cRT, little knowledge exists for adult cancer patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A systematic search of the literature was conducted using the PubMed database and the Cochrane library offering the basis for our debate of the relevance of HP axis impairment after cRT in adult cancer patients. Against the background of potential relevance for patients receiving whole brain radiotherapy (WBRT), a particular focus was set on the temporal onset of hypopituitarism and the radiation dose to the HP axis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-eight original papers with a total of 1728 patients met the inclusion criteria. Radiation doses to the HP area ranged from 4 to 97 Gray (Gy). Hypopituitarism incidences ranged from 20 to 93% for adult patients with nasopharyngeal cancer or non-pituitary brain tumors. No study focused particularly on hypopituitarism after WBRT. The onset of hypopituitarism occurred as early as within the first year following cRT (range: 3\u2009months to 25.6\u2009years). However, since most studies started follow-up evaluation only several years after cRT, early onset of hypopituitarism might have gone unnoticed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Hypopituitarism occurs frequently after cRT in adult cancer patients. Despite the general conception that it develops only after several years, onset of endocrine sequelae can occur within the first year after cRT without a clear threshold. This finding is worth debating particularly in respect of treatment options for patients with brain metastases and favorable survival prognoses.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-019-6431-5","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T09:21:31Z","timestamp":1576228891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Are hypothalamic- pituitary (HP) axis deficiencies after whole brain radiotherapy (WBRT) of relevance for adult cancer patients? \u2013 a systematic review of the literature"],"prefix":"10.1186","volume":"19","author":[{"given":"P.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. B.","family":"Fahlbusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Rades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gebauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"6431_CR1","doi-asserted-by":"crossref","unstructured":"Gebauer J, Higham C, Langer T, Denzer C, Brabant G. Long-term Endocrine and Metabolic consequences of Cancer Treatment: A Systematic Review. Endocr Rev. 2018 Nov;23.","DOI":"10.1210\/er.2018-00092"},{"issue":"5","key":"6431_CR2","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/S0360-3016(01)02788-2","volume":"52","author":"TE Merchant","year":"2002","unstructured":"Merchant TE, Goloubeva O, Pritchard DL, Gaber MW, Xiong X, Danish RK, Lustig RH. Radiation dose-volume effects on growth hormone secretion. Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1264\u201370.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"6431_CR3","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.ijrobp.2012.01.049","volume":"84","author":"C Hua","year":"2012","unstructured":"Hua C, Wu S, Chemaitilly W, Lukose RC, Merchant TE. Predicting the probability of abnormal stimulated growth hormone response in children after radiotherapy for brain tumors. Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):990\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"36","key":"6431_CR4","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1200\/JCO.2011.37.9453","volume":"29","author":"TE Merchant","year":"2011","unstructured":"Merchant TE, Rose SR, Bosley C, Wu S, Xiong X, Lustig RH. Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors. J Clin Oncol. 2011 Dec 20;29(36):4776\u201380.","journal-title":"J Clin Oncol"},{"issue":"22","key":"6431_CR5","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1200\/JCO.2008.21.2738","volume":"27","author":"TE Merchant","year":"2009","unstructured":"Merchant TE, Conklin HM, Wu S, Lustig RH, Xiong X. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits. J Clin Oncol. 2009 Aug 1;27(22):3691\u20137.","journal-title":"J Clin Oncol"},{"issue":"7","key":"6431_CR6","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1200\/JCO.2008.13.5293","volume":"26","author":"SJ Laughton","year":"2008","unstructured":"Laughton SJ, Merchant TE, Sklar CA, Kun LE, Fouladi M, Broniscer A, Morris EB, Sanders RP, Krasin MJ, Shelso J, Xiong Z, Wallace D, Gajjar A. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. J Clin Oncol. 2008 Mar 1;26(7):1112\u20138.","journal-title":"J Clin Oncol"},{"key":"6431_CR7","unstructured":"Pekic S, Miljic D, Popovic V. Hypopituitarism Following Cranial Radiotherapy. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. 2018 Oct 1."},{"issue":"1","key":"6431_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11102-008-0088-4","volume":"12","author":"KH Darzy","year":"2009","unstructured":"Darzy KH, Shalet SM. Hypopituitarism following radiotherapy. Pituitary. 2009;12(1):40\u201350.","journal-title":"Pituitary"},{"issue":"5","key":"6431_CR9","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.2014.56.7933","volume":"33","author":"W Chemaitilly","year":"2015","unstructured":"Chemaitilly W, Li Z, Huang S, Ness KK, Clark KL, Green DM, Barnes N, Armstrong GT, Krasin MJ, Srivastava DK, Pui CH, Merchant TE, Kun LE, Gajjar A, Hudson MM, Robison LL, Sklar CA. Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study. J Clin Oncol. 2015 Feb 10;33(5):492\u2013500.","journal-title":"J Clin Oncol"},{"issue":"28","key":"6431_CR10","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1200\/JCO.2018.78.1492","volume":"36","author":"RE Vatner","year":"2018","unstructured":"Vatner RE, Niemierko A, Misra M, Weyman EA, Goebel CP, Ebb DH, Jones RM, Huang MS, Mahajan A, Grosshans DR, Paulino AC, Stanley T, MacDonald SM, Tarbell NJ, Yock TI. Endocrine deficiency as a function of radiation dose to the hypothalamus and pituitary in pediatric and young adult patients with brain tumors. J Clin Oncol. 2018 Oct 1;36(28):2854\u201362.","journal-title":"J Clin Oncol"},{"issue":"8","key":"6431_CR11","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1210\/jc.2011-0306","volume":"96","author":"NM Appelman-Dijkstra","year":"2011","unstructured":"Appelman-Dijkstra NM, Kokshoorn NE, Dekkers OM, Neelis KJ, Biermasz NR, Romijn JA, Smit JW, Pereira AM. Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis. J Clin Endocrinol Metab. 2011 Aug;96(8):2330\u201340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"6431_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009 Jul 21;6(7):e1000100.","journal-title":"PLoS Med"},{"key":"6431_CR13","unstructured":"Lamba N, Bussiere MR, Niemierko A, Abedi P, Fullerton BC, Loeffler JS, Oh KS, Nachtigall LB, Shih HA. Hypopituitarism After Cranial Irradiation for Meningiomas: A Single-Institution Experience. Pract Radiat Oncol. 2019 Feb 4. pii: S1879\u20138500(19)30043\u201330048."},{"key":"6431_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.radonc.2018.10.014","volume":"130","author":"A Handisurya","year":"2019","unstructured":"Handisurya A, Rumpold T, Caucig-L\u00fctgendorf C, Flechl B, Preusser M, Ilhan-Mutlu A, Dieckmann K, Widhalm G, Grisold A, W\u00f6hrer A, Hainfellner J, Ristl R, Kurz C, Marosi C, Gessl A, Hassler M. Are hypothyroidism and hypogonadism clinically relevant in patients with malignant gliomas? A longitudinal trial in patients with glioma. Radiother Oncol. 2019 Jan;130:139\u201348.","journal-title":"Radiother Oncol"},{"issue":"3","key":"6431_CR15","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/cen.12969","volume":"84","author":"N Kyriakakis","year":"2016","unstructured":"Kyriakakis N, Lynch J, Orme SM, Gerrard G, Hatfield P, Loughrey C, Short SC, Murray RD. Pituitary dysfunction following cranial radiotherapy for adult-onset nonpituitary brain tumours. Clin Endocrinol. 2016 Mar;84(3):372\u20139.","journal-title":"Clin Endocrinol"},{"issue":"7","key":"6431_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1055\/s-0035-1549963","volume":"123","author":"SH Ipekci","year":"2015","unstructured":"Ipekci SH, Cakir M, Kiyici A, Koc O, Artac M. Radiotherapy-induced hypopituitarism in nasopharyngeal carcinoma: the tip of an iceberg. Exp Clin Endocrinol Diabetes. 2015 Jul;123(7):411\u20138.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"6431_CR17","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11102-014-0593-6","volume":"18","author":"J Ratnasingam","year":"2015","unstructured":"Ratnasingam J, Karim N, Paramasivam SS, Ibrahim L, Lim LL, Tan AT, Vethakkan SR, Jalaludin A, Chan SP. Hypothalamic pituitary dysfunction amongst nasopharyngeal cancer survivors. Pituitary. 2015 Aug;18(4):448\u201355.","journal-title":"Pituitary."},{"issue":"4","key":"6431_CR18","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s11764-015-0439-x","volume":"9","author":"M Seland","year":"2015","unstructured":"Seland M, Bj\u00f8ro T, Furre T, Schreiner T, Bollerslev J, Foss\u00e5 SD, Loge JH, Holte H, Kiserud CE. Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region. J Cancer Surviv. 2015 Dec;9(4):630\u201340.","journal-title":"J Cancer Surviv"},{"issue":"1","key":"6431_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.radonc.2014.08.018","volume":"113","author":"NM Appelman-Dijkstra","year":"2014","unstructured":"Appelman-Dijkstra NM, Malgo F, Neelis KJ, Coremans I, Biermasz NR, Pereira AM. Pituitary dysfunction in adult patients after cranial irradiation for head and nasopharyngeal tumours. Radiother Oncol. 2014 Oct;113(1):102\u20137.","journal-title":"Radiother Oncol"},{"issue":"1","key":"6431_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.radonc.2011.02.015","volume":"99","author":"S Madaschi","year":"2011","unstructured":"Madaschi S, Fiorino C, Losa M, Lanzi R, Mazza E, Motta M, Perna L, Brioschi E, Scavini M, Reni M. Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors. Radiother Oncol. 2011 Apr;99(1):23\u20138.","journal-title":"Radiother Oncol"},{"key":"6431_CR21","doi-asserted-by":"publisher","unstructured":"Snyers A, Janssens GO, Twickler MB, Hermus AR, Takes RP, Kappelle AC, Merkx MA, Dirix P, Kaanders JH. Malignant tumors of the nasal cavity and paranasal sinuses: long-term outcome and morbidity with emphasis on hypothalamic-pituitary deficiency. Int J Radiat Oncol Biol Phys 2009 Apr 1;73(5):1343\u20131351. doi: https:\/\/doi.org\/10.1016\/j.ijrobp.2008.07.040. Epub 2008 Oct 27.","DOI":"10.1016\/j.ijrobp.2008.07.040"},{"issue":"9","key":"6431_CR22","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/hed.20847","volume":"30","author":"N Bhandare","year":"2008","unstructured":"Bhandare N, Kennedy L, Malyapa RS, Morris CG, Mendenhall WM. Hypopituitarism after radiotherapy for extracranial head and neck cancers. Head Neck. 2008 Sep;30(9):1182\u201392.","journal-title":"Head Neck"},{"issue":"4","key":"6431_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1530\/eje.1.02272","volume":"155","author":"HJ Schneider","year":"2006","unstructured":"Schneider HJ, Rovere S, Corneli G, Croce CG, Gasco V, Rud\u00e0 R, Grottoli S, Stalla GK, Soffietti R, Ghigo E, Aimaretti G. Endocrine dysfunction in patients operated on for non-pituitary intracranial tumors. Eur J Endocrinol. 2006 Oct;155(4):559\u201366.","journal-title":"Eur J Endocrinol"},{"key":"6431_CR24","doi-asserted-by":"crossref","unstructured":"Agha A, Sherlock M, Brennan S, O'Connor SA, O'Sullivan E, Rogers B, Faul C, Rawluk D, Tormey W, Thompson CJ Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J Clin Endocrinol Metab 2005 Dec;90(12):6355\u20136360. Epub 2005 Sep 6.","DOI":"10.1210\/jc.2005-1525"},{"issue":"2","key":"6431_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0167-8140(03)00192-0","volume":"69","author":"TB Johannesen","year":"2003","unstructured":"Johannesen TB, Lien HH, Hole KH, Lote K. Radiological and clinical assessment of long-term brain tumour survivors after radiotherapy. Radiother Oncol. 2003 Nov;69(2):169\u201376.","journal-title":"Radiother Oncol"},{"issue":"5","key":"6431_CR26","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1210\/jcem.87.5.8485","volume":"87","author":"V Popovic","year":"2002","unstructured":"Popovic V, Pekic S, Golubicic I, Doknic M, Dieguez C, Casanueva FF. The impact of cranial irradiation on GH responsiveness to GHRH plus GH-releasing peptide-6. J Clin Endocrinol Metab. 2002 May;87(5):2095\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"6431_CR27","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0360-3016(00)01387-0","volume":"49","author":"HH Pai","year":"2001","unstructured":"Pai HH, Thornton A, Katznelson L, Finkelstein DM, Adams JA, Fullerton BC, Loeffler JS, Leibsch NJ, Klibanski A, Munzenrider JE. Hypothalamic\/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):1079\u201392.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"6431_CR28","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1212\/WNL.49.2.498","volume":"49","author":"W Arlt","year":"1997","unstructured":"Arlt W, Hove U, M\u00fcller B, Reincke M, Berweiler U, Schwab F, Allolio B. Frequent and frequently overlooked: treatment-induced endocrine dysfunction in adult long-term survivors of primary brain tumors. Neurology. 1997 Aug;49(2):498\u2013506.","journal-title":"Neurology."},{"issue":"2","key":"6431_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/BF01057753","volume":"25","author":"MJ Taphoorn","year":"1995","unstructured":"Taphoorn MJ, Heimans JJ, van der Veen EA, Karim AB. Endocrine functions in long-term survivors of low-grade supratentorial glioma treated with radiation therapy. J Neuro-Oncol. 1995;25(2):97\u2013102.","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"6431_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1056\/NEJM199301143280203","volume":"328","author":"LS Constine","year":"1993","unstructured":"Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF, Rubin P. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med. 1993 Jan 14;328(2):87\u201394.","journal-title":"N Engl J Med"},{"issue":"286","key":"6431_CR31","first-page":"165","volume":"78","author":"KS Lam","year":"1991","unstructured":"Lam KS, Tse VK, Wang C, Yeung RT, Ho JH. Effects of cranial irradiation on hypothalamic-pituitary function--a 5-year longitudinal study in patients with nasopharyngeal carcinoma. Q J Med. 1991 Feb;78(286):165\u201376.","journal-title":"Q J Med"},{"issue":"10","key":"6431_CR32","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1136\/jnnp.51.10.1302","volume":"51","author":"E Woo","year":"1988","unstructured":"Woo E, Lam K, Yu YL, Ma J, Wang C, Yeung RT. Temporal lobe and hypothalamic-pituitary dysfunctions after radiotherapy for nasopharyngeal carcinoma: a distinct clinical syndrome. J Neurol Neurosurg Psychiatry. 1988 Oct;51(10):1302\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"6431_CR33","first-page":"364","volume":"109","author":"NA Samaan","year":"1987","unstructured":"Samaan NA, Schultz PN, Yang KP, Vassilopoulou-Sellin R, Maor MH, Cangir A, Goepfert H. Endocrine complications after radiotherapy for tumors of the head and neck. J Lab Clin Med. 1987 Mar;109(3):364\u201372.","journal-title":"J Lab Clin Med"},{"issue":"9","key":"6431_CR34","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/0360-3016(87)90227-6","volume":"13","author":"KS Lam","year":"1987","unstructured":"Lam KS, Ho JH, Lee AW, Tse VK, Chan PK, Wang C, Ma JT, Yeung RT. Symptomatic hypothalamic-pituitary dysfunction in nasopharyngeal carcinoma patients following radiation therapy: a retrospective study. Int J Radiat Oncol Biol Phys. 1987 Sep;13(9):1343\u201350.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"6431_CR35","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3171\/jns.1986.65.4.0490","volume":"65","author":"JI Mechanick","year":"1986","unstructured":"Mechanick JI, Hochberg FH, LaRocque A. Hypothalamic dysfunction following whole-brain irradiation. J Neurosurg. 1986 Oct;65(4):490\u20134.","journal-title":"J Neurosurg"},{"issue":"6","key":"6431_CR36","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1365-2265.1986.tb01660.x","volume":"24","author":"KS Lam","year":"1986","unstructured":"Lam KS, Wang C, Yeung RT, Ma JT, Ho JH, Tse VK, Ling N. Hypothalamic hypopituitarism following cranial irradiation for nasopharyngeal carcinoma. Clin Endocrinol. 1986 Jun;24(6):643\u201351.","journal-title":"Clin Endocrinol"},{"issue":"8","key":"6431_CR37","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/BF03349671","volume":"17","author":"TS Huang","year":"1994","unstructured":"Huang TS, Huang SC, Hsu MM. A prospective study of hypothalamus pituitary function after cranial irradiation with or without radiosensitizing chemotherapy. J Endocrinol Investig. 1994 Sep;17(8):615\u201323.","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"6431_CR38","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1365-2265.1976.tb01960.x","volume":"5","author":"JS Harrop","year":"1976","unstructured":"Harrop JS, Davies TJ, Capra LG, Marks V. Hypothalamic-pituitary function following successful treatment of intracranial tumours. Clin Endocrinol. 1976 Jul;5(4):313\u201321.","journal-title":"Clin Endocrinol"},{"issue":"14","key":"6431_CR39","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1001\/jama.1976.03270150025024","volume":"236","author":"MB Rosenthal","year":"1976","unstructured":"Rosenthal MB, Goldfine ID. Primary and secondary hypothyroidism in nasopharyngeal carcinoma. JAMA. 1976 Oct 4;236(14):1591\u20133.","journal-title":"JAMA"},{"issue":"11","key":"6431_CR40","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/0360-3016(82)90442-4","volume":"8","author":"NA Samaan","year":"1982","unstructured":"Samaan NA, Vieto R, Schultz PN, Maor M, Meoz RT, Sampiere VA, Cangir A, Ried HL, Jesse RH Jr. Hypothalamic, pituitary and thyroid dysfunction after radiotherapy to the head and neck. Int J Radiat Oncol Biol Phys. 1982 Nov;8(11):1857\u201367.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"6431_CR41","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1200\/JCO.2005.04.6185","volume":"24","author":"D Khuntia","year":"2006","unstructured":"Khuntia D, Brown P, Li J, Mehta MP. Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol. 2006 Mar 10;24(8):1295\u2013304.","journal-title":"J Clin Oncol"},{"issue":"9422","key":"6431_CR42","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","volume":"363","author":"DW Andrews","year":"2004","unstructured":"Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ Jr. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004 May 22;363(9422):1665\u201372.","journal-title":"Lancet"},{"issue":"21","key":"6431_CR43","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","volume":"295","author":"H Aoyama","year":"2006","unstructured":"Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006 Jun 7;295(21):2483\u201391.","journal-title":"JAMA"},{"issue":"2","key":"6431_CR44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","volume":"29","author":"M Kocher","year":"2011","unstructured":"Kocher M, Soffietti R, Abacioglu U, Vill\u00e0 S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol. 2011 Jan 10;29(2):134\u201341.","journal-title":"J Clin Oncol"},{"issue":"4","key":"6431_CR45","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","volume":"15","author":"M Yamamoto","year":"2014","unstructured":"Yamamoto M, Serizawa T, Shuto T, Akabane A, Higuchi Y, Kawagishi J, Yamanaka K, Sato Y, Jokura H, Yomo S, Nagano O, Kenai H, Moriki A, Suzuki S, Kida Y, Iwai Y, Hayashi M, Onishi H, Gondo M, Sato M, Akimitsu T, Kubo K, Kikuchi Y, Shibasaki T, Goto T, Takanashi M, Mori Y, Takakura K, Saeki N, Kunieda E, Aoyama H, Momoshima S, Tsuchiya K. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol. 2014 Apr;15(4):387\u201395.","journal-title":"Lancet Oncol"},{"issue":"4","key":"6431_CR46","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","volume":"37","author":"L Gaspar","year":"1997","unstructured":"Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):745\u201351.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"6431_CR47","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ijrobp.2009.08.025","volume":"77","author":"PW Sperduto","year":"2010","unstructured":"Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):655\u201361.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"6431_CR48","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00066-008-1831-5","volume":"184","author":"D Rades","year":"2008","unstructured":"Rades D, Dunst J, Schild SE. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol. 2008 May;184(5):251\u20135.","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"6431_CR49","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s00066-013-0308-3","volume":"189","author":"L Dziggel","year":"2013","unstructured":"Dziggel L, Segedin B, Podvrsnik NH, Oblak I, Schild SE, Rades D. Validation of a survival score for patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol. 2013 May;189(5):364\u20136.","journal-title":"Strahlenther Onkol"},{"issue":"7","key":"6431_CR50","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJM199908123410703","volume":"341","author":"A Aup\u00e9rin","year":"1999","unstructured":"Aup\u00e9rin A, Arriagada R, Pignon JP, Le P\u00e9choux C, Gregor A, Stephens RJ, Kristjansen PE, Johnson BE, Ueoka H, Wagner H, Aisner J. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic cranial irradiation overview collaborative group. N Engl J Med. 1999 Aug 12;341(7):476\u201384.","journal-title":"N Engl J Med"},{"issue":"9962","key":"6431_CR51","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0140-6736(14)61085-0","volume":"385","author":"BJ Slotman","year":"2015","unstructured":"Slotman BJ, van Tinteren H, Praag JO, Knegjens JL, El Sharouni SY, Hatton M, Keijser A, Faivre-Finn C, Senan S. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. Lancet. 2015 Jan 3;385(9962):36\u201342.","journal-title":"Lancet."},{"issue":"1","key":"6431_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/JOE-09-0412","volume":"205","author":"MH Warner","year":"2010","unstructured":"Warner MH, Beckett GJ. Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol. 2010 Apr;205(1):1\u201313.","journal-title":"J Endocrinol"},{"issue":"1","key":"6431_CR53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00066-008-1795-5","volume":"184","author":"D Rades","year":"2008","unstructured":"Rades D, Bohlen G, Dunst J, Lohynska R, Veninga T, Stalpers L, Schild SE, Dahm-Daphi J. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases. Strahlenther Onkol. 2008 Jan;184(1):30\u20135.","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"6431_CR54","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ijrobp.2009.08.022","volume":"78","author":"D Rades","year":"2010","unstructured":"Rades D, Heisterkamp C, Schild SE. Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose? Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):398\u2013403.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"6431_CR55","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1002\/cncr.26680","volume":"118","author":"D Rades","year":"2012","unstructured":"Rades D, Panzner A, Dziggel L, Haatanen T, Lohynska R, Schild SE. Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis. Cancer. 2012 Aug 1;118(15):3852\u20139.","journal-title":"Cancer"},{"key":"6431_CR56","doi-asserted-by":"crossref","unstructured":"Kyriakakis N, Lynch J, Orme SM, Gerrard G, Hatfield P, Short SC, Loughrey C, Murray RD. Hypothalamic-pituitary axis irradiation dose thresholds for the development of hypopituitarism in adult-onset gliomas. Clin Endocrinol (Oxf). 2019 Mar 15.","DOI":"10.1111\/cen.13971"},{"key":"6431_CR57","unstructured":"Pekic S, Miljic D, Popovic V. Hypopituitarism Following Cranial Radiotherapy. 2018 Oct 1. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [internet]. South Dartmouth (MA): MDText.com, Inc."},{"issue":"5","key":"6431_CR58","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1586\/era.12.27","volume":"12","author":"T Sathyapalan","year":"2012","unstructured":"Sathyapalan T, Dixit S. Radiotherapy-induced hypopituitarism: a review. Expert Rev Anticancer Ther. 2012 May;12(5):669\u201383.","journal-title":"Expert Rev Anticancer Ther"},{"key":"6431_CR59","unstructured":"Ahmad A. Altered fractionation. In: Perez and Brady\u2019s Principles and Practice of Radiation Oncology, sixth edition 2013."},{"issue":"262","key":"6431_CR60","first-page":"145","volume":"70","author":"MD Littley","year":"1989","unstructured":"Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML. Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med. 1989 Feb;70(262):145\u201360.","journal-title":"Q J Med"},{"issue":"7","key":"6431_CR61","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S2213-8587(15)00008-X","volume":"3","author":"E Crowne","year":"2015","unstructured":"Crowne E, Gleeson H, Benghiat H, Sanghera P, Toogood A. Effect of cancer treatment on hypothalamic-pituitary function. Lancet Diabetes Endocrinol. 2015 Jul;3(7):568\u201376.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"6431_CR62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0360-3016(02)02888-2","volume":"54","author":"TE Merchant","year":"2002","unstructured":"Merchant TE, Williams T, Smith JM, Rose SR, Danish RK, Burghen GA, Kun LE, Lustig RH. Preirradiation endocrinopathies in pediatric brain tumor patients determined by dynamic tests of endocrine function. Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):45\u201350.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6431-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6431-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6431-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:13:54Z","timestamp":1607645634000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6431-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6431"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6431-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"25 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DR and SJ are editorial board members of BMC Cancer. All authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1213"}}